Evaluation of anti-gingivitis benefits of stannous fluoride dentifrice among triclosan dentifrice users

American Journal of Dentistry

Volumn 26, Issue 4, 2013, Pages 175-179

  He, Tao ^a   Barker, Matthew L ^a   Biesbrock, Aaron ^a   Miner, Melanie ^a   Amini, Pejmon ^b   Ram Goyal, C ^b   Qaqish, Jimmy ^b  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b BioSci Research America Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREST PRO HEALTH DENTIFRICE; CREST PRO-HEALTH DENTIFRICE; HYDRATED SILICA GEL BASED TOOTHPASTE; HYDRATED SILICA GEL-BASED TOOTHPASTE; PHOSPHATE; SILICIC ACID; TIN FLUORIDE; TOOTHPASTE; TOPICAL ANTIINFECTIVE AGENT; TRICLOSAN;

ADULT; AGED; ARTICLE; BIOAVAILABILITY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GINGIVA BLEEDING; GINGIVITIS; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PERIODONTICS; RANDOMIZED CONTROLLED TRIAL; TOOTH BRUSHING; YOUNG ADULT;

ADULT; AGED; ANTI-INFECTIVE AGENTS, LOCAL; BIOLOGICAL AVAILABILITY; DENTIFRICES; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GINGIVAL HEMORRHAGE; GINGIVITIS; HUMANS; MALE; MIDDLE AGED; PERIODONTAL INDEX; PHOSPHATES; SILICIC ACID; TIN FLUORIDES; TOOTHBRUSHING; TOOTHPASTES; TRICLOSAN; YOUNG ADULT;

EID: 84887852015     PISSN: 08948275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Thase ME, Blomgren SL, Birkett MA, Apter JT, Tepner KG. Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline. J Clin Psychiatry 1997;58;16-21.
2. Thase ME, Feighner JP, Lydiard RB. Citalopram treatment of fluoxetine nonresponders. J Clin Psychiatry 2001;62;683-687.
3. Little JT, Ketter TA, Kimbrell TA, Danielson A, Benson B, Willis MW, Post KM. Venlafaxine or bupropion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controls. Psychopharmacol Bull 1996;32:629-635.
4. Carlsen KH, Kramer J, Fagertun HE. Loratadine and terfenadine in perennial allergic rhinitis. Treatment of nonresponders to the one drug with the other drug. Allergy 1993;48;431-436.
5. Prenner BM, Capano D, Harris AG. Efficacy and tolerability of loratadine versus fexofenadine in the treatment of seasonal allergic rhinitis: A doubleblind comparison wim crossover treatment of nonresponders. Clin Ther 2000;22:760-769.
6. Ellis AK, Kafeiro E, Day JH. Quality of life indices may be predictive of placebo and medication response to treatment for allergic rhinitis. Ann Allergy Asthma Immunol 2001;86;393-396.
7. Hoyeraal HM, Fagertun H, Ingemann-Hansen T, Ersmark H, Ronn O. Characterization of responders and nonresponders to tiaprofenic acid and naproxen in the treatment of patients with osteoarthritis. J Rheumatol 1993;20:1747-1752.
8. Walker JS, Sheather-Keid KB, Carmody JJ, Vial JH, Day RO. Nonsteroidal anti-inflammatory drugs in rheumatoid arthritis and osteoarthritis: Support for the concept of "responders" and "non-responders". Arthritis Rheum 1997;40:1944-1954.
9. Del Puente A, Scognamiglio A, Itto E, Ferrara G, Oriente P. Intramuscular clodronate in nonresponders to oral alendronate therapy for osteoporosis. J Rheumatol 2000;27:1980-1983.
10. Delva NJ, Brunet DG, Hawken ER, Kesteven RM, Lawson JS, Lywood DW, Rodenburg M, Waldron JJ. Characteristics of responders and nonresponders to brief-pulse right unilateral ECT in a controlled clinical trial. J ECT 2001;17:118-123.
11. Archila L, He T, Winston JL, Biesbrock AR, McCIanahan SF, Bartizek RD. Antigingivitis efficacy of a stabilized stannous fluoride/sodium hexametaphosphate dentifrice in subjects previously nonresponsive to a triclosan/copolymer dentifrice. Compend Contin Educ Dent 2005;26(Suppll):12-18.
12. Putt MS, Milleman JL, Milleman KR, Bartizek RD, Winston JL, He T. Anti-gingivitis efficacy of stannous fluoride dentifrice among triclosan users. J Dent Res 2007;86(Sp Is): Abstr 1071.
13. Lobene RR, Weatherford T, Ross NM, Lamm RA, Menaker L. A modified gingival index for use in clinical trials. Clin Prev Dent 1986;8:3-6.
14. Saxton CA, Van Der Ouderaa FJ. The effect of a dentifrice containing zinc citrate and triclosan on developing gingivitis. J Periodontal Res 1989;24:75-80.
15. McCIanahan SF, Beiswanger BB, Bartizek RD, Lanzalaco AC, Bacca L, White DJ. A comparison of stabilized stannous fluoride dentifrice and triclosan/copolymer dentifrice for efficacy in the reduction of gingivitis and gingival bleeding: Six-month clinical results. J Clin Dent 1997;8(2 Sp Is):39-45.
16. Tinanof FN. Review of the antimicrobial action of stannous fluoride. J Clin Dent 1990;2:22-27.
17. Palomo F, Wantland L, Sanchez A, Volpe AR, McCool J, De Vizio W. The effect of three commercially available dentifrices containing triclosan on supragingjval plaque formation and gingivitis: A six month clinical study. Int Dent J 1994;44(Suppl 1):75-81.
18. Mankodi S, Walker C, Conforti N, De Vizio W, McCool JJ, Volpe AR. Clinical effect of a triclosan-containing dentifrice on plaque and gingivitis: A six-month study. Clin Prev Dent 1992;14:4-10.
19. He T, Barker ML, Goyal CR, Biesbrock AR. Anti-gingivitis effects of a novel 0.454% stabilized stannous fluoride dentifrice relative to a positive control. Am J Dent 2012;25:136-140.
20. He T, Barker ML, Biesbrock AR, Sharma NC, Qaqish J, Goyal CR. Assessment of the effects of a stannous fluoride dentifrice on gingivitis in a two-month positive-controlled clinical study. J Clin Dent 2012;23:80-85.
21. Archila L, Bartizek RD, Winston L, Biesbrock AR, McCIanahan SF, He T. The comparative efficacy of stabilized stannous fluoride/sodium hexametaphosphate dentifrice and sodium fluoride/triclosan/copolymer dentifrice for the control of gingivitis: A 6-month randomized clinical study. J Periodontal 2004;75:1592-1599.
22. Johnson PO, Neyman J. Tests of certain linear hypotheses and their applications to some educational problems. Stat Res Memoirs 1936;1:57-93.